Multiorgan Failure and Omicron: A Suspected Case of Post-COVID-19 Cholangiopathy.

cholangiopathy coronavirus covid cholangiopathy covid-19 gastroenterology hepatology ssc ssc-cip

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
Feb 2023
Historique:
accepted: 15 02 2023
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 21 3 2023
Statut: epublish

Résumé

Since the declaration of a global pandemic by the World Health Organization on March 11, 2020, coronavirus disease 2019 (COVID-19) has impacted millions worldwide. This complex disease process has been primarily associated with respiratory illness. As we continue to learn about COVID-19, there appears to be a growing spectrum of non-pulmonary manifestations. A major topic of interest is hepatic dysfunction related to COVID-19, specifically the growing number of cases involving acute liver failure in the setting of COVID-19. Here, we present a rare case of a patient with COVID-19 antibodies, negative inpatient COVID-19 testing, jaundice, and elusive multiorgan dysfunction.

Identifiants

pubmed: 36938182
doi: 10.7759/cureus.35010
pmc: PMC10021348
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e35010

Informations de copyright

Copyright © 2023, Anguiano-Albarran et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Transplant Proc. 2021 May;53(4):1132-1137
pubmed: 33846012
Chonnam Med J. 2022 Jan;58(1):1-5
pubmed: 35169552
J Infect. 2022 Apr;84(4):e13-e15
pubmed: 35123960
J Hepatol. 2020 Nov;73(5):1063-1071
pubmed: 32526252
Front Med (Lausanne). 2021 Apr 22;8:603374
pubmed: 33968947
Hepatology. 2020 Jul;72(1):287-304
pubmed: 32298473
Int J Biol Sci. 2021 Jan 1;17(1):62-72
pubmed: 33390833
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
J Biol Chem. 1994 Jun 24;269(25):17146-51
pubmed: 8006021
Clin J Gastroenterol. 2021 Oct;14(5):1503-1510
pubmed: 34228348
Hepatology. 2022 Dec;76(6):1560-1562
pubmed: 35822670
Clin Infect Dis. 2020 Jul 28;71(15):762-768
pubmed: 32161940
Redox Biol. 2021 Oct;46:102109
pubmed: 34455146
Pharmacol Res. 2020 Jul;157:104833
pubmed: 32302706
J Inorg Biochem. 2014 Nov;140:245-54
pubmed: 25193127
J Clin Pharm Ther. 2007 Oct;32(5):483-7
pubmed: 17875115
Hepatology. 2022 Dec;76(6):1563-1575
pubmed: 35596929

Auteurs

Ricardo Anguiano-Albarran (R)

Internal Medicine, Texas Christian University School of Medicine - Internal Medicine Residency Program, Fort Worth, USA.

Daniel Cain (D)

Internal Medicine, Texas Christian University School of Medicine - Internal Medicine Residency Program, Fort Worth, USA.

Mohammad Ashfaq (M)

Transplant Hepatology, Baylor Simmons Transplant Institute, Baylor Scott & White All Saints Medical Center, Fort Worth, USA.
Graduate Medical Education, Texas Christian University School of Medicine - Internal Medicine Residency Program, Fort Worth, USA.

Apurva Modi (A)

Transplant Hepatology, Baylor Simmons Transplant Institute, Baylor Scott & White All Saints Medical Center, Fort Worth, USA.
Graduate Medical Education, Texas Christian University School of Medicine - Internal Medicine Residency Program, Fort Worth, USA.

Shovendra Gautam (S)

Graduate Medical Education, Texas Christian University School of Medicine - Internal Medicine Residency Program, Fort Worth, USA.

Classifications MeSH